Health Bulletin 29/January/2024

Published On 2024-01-29 11:46 GMT   |   Update On 2024-01-29 11:46 GMT

Here are the top health news for the day:Three drug treatment regime to be introduced to stop leprosy transmission by 2027The Union Health Ministry has decided to implement a new treatment regimen for leprosy aimed at stopping its transmission at the sub-national level by 2027, three years ahead of the Sustainable Development Goals. The Ministry of Health has decided to introduce a...

Login or Register to read the full article

Here are the top health news for the day:

Three drug treatment regime to be introduced to stop leprosy transmission by 2027

The Union Health Ministry has decided to implement a new treatment regimen for leprosy aimed at stopping its transmission at the sub-national level by 2027, three years ahead of the Sustainable Development Goals. The Ministry of Health has decided to introduce a three-drug regimen for Pauci-Bacillary (PB) cases in place of a two-drug regimen for six months, according to the latest globally accepted scientific research studies and evidence-based practices.

For the full story, check out the link given below:

Centre To Introduce Three Drug Treatment Regime To Stop Leprosy Transmission By 2027


CDSCO Panel gives a green signal to Biological E to study vaccines for 6- 8 weeks old infants

Reviewing the Phase I clinical trial report, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has approved the vaccine maker Biological E to conduct a Phase II clinical trial of Diphtheria, Tetanus, Pertussis (Whole cell), Hepatitis B (rDNA), inactivated Poliomyelitis and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed) for 6- 8 weeks-old infants.

This came after the vaccine maker Biological E presented its proposal for the conduct of a Phase II clinical trial in 6- 8 weeks-old infants along with a Phase I clinical trial report.

For the full story, check out the link given below:

Biological E Gets CDSCO Panel Nod To Study Vaccine For 6- 8 Weeks Old Infants


A 2 kg preterm baby suffering from TGA saved in a 7-hour surgery

In probably one of the first in the private healthcare sector in the Uttar Pradesh, a two kg pre-term baby was born to a young couple and diagnosed to have a condition called TGA (Transposition of Great Arteries).

The baby was put on prostaglandin, a lifesaving medicine and transferred to Tender Palm Hospital in Lucknow, under the care of Dr Vijay Agarwal, senior surgeon.

The child underwent a seven hour-long and difficult surgery by Dr Vijay Agarwal and his team and after keeping the chest open for 24 hours and with a lot of hard work by ICU nursing staff and expert intensivist and paediatrician, he was successfully removed from the ventilator after three days.

For the full story, check out the link given below:

Doctors At UP Hospital Saves 2 Kg Preterm Baby Suffering From TGA In 7 Hour Surgery


Haryana Surgeon slapped Rs 8 lakh compensation for performing Open Surgery instead of Laparoscopic Surgery

The National Consumer Disputes Redressal Commission (NCDRC) recently directed a Haryana-based doctor to pay Rs 8 lakh compensation to the family of a patient, who died after undergoing surgery for swelling in the intestine.

The NCDRC bench upheld the State Commission's order after noting that doctor performed open surgery even though he had informed the relatives that a laparoscopic surgery would be conducted. Consequently, the surgery led to Septicaemia and after fighting for her life for more than a month, the patient died.

For the full story, check out the link given below:

Open Surgery Instead Of Laparoscopic Surgery: Haryana Surgeon Slapped Rs 8 Lakh Compensation

Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Health Bulletin 13/ May/ 2024
Health Bulletin 11/ May/ 2024
Health bulletin 10/ May/ 2024
Health Bulletin 09/ May/ 2024
Health Bulletin 08/ May/ 2024
Health Bulletin 07/ May/ 2024
Health Bulletin 06/ May/ 2024
Health Bulletin 04/ May/ 2024